Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer

Published:2015-10 Issue:10 Volume:10 Page:1458-1467
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Pujol Jean-Louis,Vansteenkiste Johan F.,Pas Tommaso Martino De,Atanackovic Djordje,Reck Martin,Thomeer Michiel,Douillard Jean-Yves,Fasola Gianpiero,Potter Vanessa,Taylor Paul,Bosquée Lionel,Scheubel Robert,Jarnjak Silvija,Debois Muriel,de Sousa Alves Pedro,Louahed Jamila,Brichard Vincent G.,Lehmann Frédéric F.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference50 articles.

1. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Peters;Ann Oncol,2012

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

4. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2013

5. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer;Aging;2024-01-04

2. Advances, opportunities and challenges in developing therapeutic cancer vaccines;Critical Reviews in Oncology/Hematology;2024-01

3. Synergistic Potential of Antigen-Specific Vaccines and Immunomodulatory Agents for Lung Cancer Treatment;Immunotherapy Against Lung Cancer;2024

4. Cancer vaccines: from an immunology perspective;Immunotherapy Advances;2023-12-21

5. Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy;Biomedicine & Pharmacotherapy;2023-10